Jinxin Fertility Group (HKSE:01951) 5-Year EBITDA Growth Rate : 8.00% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Jinxin Fertility Group 5-Year EBITDA Growth Rate?

Jinxin Fertility Group's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.09.

During the past 12 months, Jinxin Fertility Group's average EBITDA Per Share Growth Rate was 59.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jinxin Fertility Group was 72.50% per year. The lowest was -15.20% per year. And the median was 20.60% per year.

Competitive Comparison of Jinxin Fertility Group's 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Jinxin Fertility Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jinxin Fertility Group's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jinxin Fertility Group's 5-Year EBITDA Growth Rate falls into.

Jinxin Fertility Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jinxin Fertility Group (HKSE:01951) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Jinxin Fertility Group 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jinxin Fertility Group's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinxin Fertility Group (HKSE:01951) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jinxin Fertility Group Ltd (HKSE:01951) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

3NX:Germany

Address

No. 301, North Jingsha Road, Jinjiang District, Sichuan, Chengdu, CHN

Website

https://www.jxr-fertility.com

Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm generates its revenue from Assisted reproductive services, management services, and ancillary medical services. Geographically, it generates a majority of its revenue from the People's Republic of China.

Executives

Jinxin Fertility Investment Group Limited	2101 Beneficial owner
Hrc Investment Holding, Llc
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

Jinxin Fertility Group (HKSE:01951) Headlines

No Headlines